University of Minnesota
Minneapolis, Minnesota, 55455, United States
NCT Number: NCT00397436
The main focus of this pilot study is to construct a fairly complete protein profile of the epidermis. This will allow us to study how the epidermis responds to external stressors such as ultra-violet. We hypothesize that by using the cutting edge technology, proteomics, we will be able to construct a fairly complete profile of different epidermal cells (keratinocytes, epidermal nerve fibers (ENFs), melanocytes, Langerhans cell,...etc) of normal and ultraviolet (UV) irradiated skin.
Looking for future studies?
Notify Me18 year–30 year
Male
Interventional
Early Phase 1
Minneapolis, Minnesota, 55455, United States
We will investigate the changes of the epidermal cell proteome after UV irradiation to the forearms of healthy young male volunteers. Knowledge of specific molecular markers may provide knowledge of basic biological systems and possibly targeted therapy of inflammation.
By using combined proteomic methodologies we will be able to quantify protein changes at cytoplasmic and membrane protein levels of epidermal cells in normal vs. irradiated skins.
This study may allow us to obtain fairly comprehensive profile of membrane integrated and cytoplasmic proteins of epidermal cell populations which will facilitate our understand of biological responses to UV irradiation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
UV irradiation
Other names: UV irradiation.
Time frame: 1 year
Time frame: 1 year
University of Minnesota
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04851145
Graft Rejection, Humoral Immunity
Bordeaux, France
View Trial DetailsNCT07416318
Head and Neck Neoplasms, Leukoplakia
Kocaeli, Turkey (Türkiye)
View Trial DetailsNCT06365320
Lactate, Metabolomics
Reus, Tarragona, Spain
View Trial DetailsNCT02514070
Lipoprotein Metabolism, PCSK9
Bethesda, Maryland, United States
View Trial Details